Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease

Gut

Volumn 59, Issue 12, 2010, Pages 1731-1732

  Ford, Alexander C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; PLACEBO;

CLINICAL TRIAL; CROHN DISEASE; DISEASE ACTIVITY; DRUG EFFICACY; HUMAN; INTESTINE RESECTION; LETTER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELAPSE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; CROHN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE; RECURRENCE; RESEARCH DESIGN;

EID: 78649848039     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.218941     Document Type: Letter

References (6)

1. Reinisch W, Angelberger S, Petritsch W, et al. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy multi-centre trial. Gut 2010;59:752-9.
2. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995;109:404-13.
3. Lochs H, Mayer M, Fleig WE, et al. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI. Gastroenterology 2000;118:264-73.
4. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004;127:723-9.
5. D'Haens G, Vermeire S, van Assche G, et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a randomized controlled trial. Gastroenterology 2008;135:1123-9.
6. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004;127:730-40.